May 16, 2017   SOURCE: BusinessWire

Coveris Reports First Quarter 2017 Financial Results

Coveris Holdings S.A. reported net sales of $598 million for the first quarter of 2017 versus $639 million in the first quarter of 2016. Excluding a $35 million impact of currency, the first quarter sales were down about 1% compared with the same quarter in the prior year.

Adjusted EBITDA for the quarter was $59 million, compared to $75 million for the same period in the prior year. Currency accounted for approximately $4 million of the decline. The decline is primarily related to softer volumes and product mix, particularly in the Company’s flexibles business in the US and UK.

“First quarter volumes were soft but in line with our expectations,” said David Mezzanotte, Chairman and Interim Chief Executive Officer. “Over the past few months, we have addressed many of the operational and commercial issues we uncovered in the latter half of 2016. We are beginning to see positive improvements and I remain optimistic about the second half of this year as we focus on top line growth and drive customer care initiatives.”

Please see our Adjusted EBITDA Reconciliation attached to this press release. Additional financial information may be found on www.coveris.com under the Investor Relations section.

EARNINGS CALL

A conference call hosted by management to discuss these financial results will be held on May 17, at 11:00 am, Eastern. The conference call number is 877-407-8031 (domestic) or 201-689-8031 (international). A replay of the call will be available after 1:30 pm, Eastern on May 17 until May 31, 2017, by dialling 877-481-4010 (domestic) or 919-882-2331 (international) with the conference ID of 10371.

ABOUT COVERIS

As a leading international manufacturing company, Coveris is dedicated to providing solutions that enhance the safety, quality and convenience of products we use every day. In partnership with the most respected brands in the world, Coveris develops vital products that protect everything from the food we eat, to medical supplies, to the touch screen device in our pockets, contributing to the lives of millions every day. Coveris is an affiliated portfolio company of Sun Capital Partners, Inc.

FORWARD-LOOKING STATEMENTS:

Statements in this release that are not historical are “forward-looking statements.” Forward-looking statements may be identified by the use of forward-looking terminology such as the words “should,” “would,” “could,” “will,” “may,” “expect,” “believe,” “anticipate,” “attempt,” “project” and other terms with similar meaning indicating possible future events or potential impact on our business. You are cautioned not to place undue reliance on these forward-looking statements, which are not guarantees of future performance. These statements are based on management's current assumptions, beliefs and expectations, all of which involve a number of business risks and uncertainties that could cause actual results to differ materially. The forward-looking statements in this release are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect Coveris’ operations, markets, products, services, prices and other factors. Significant risks and uncertainties may relate to, but are not limited to, financial, economic, competitive, environmental, political, legal, regulatory and technological factors. In addition, any forward-looking statements are made only as of the date of this release, and Coveris does not intend and does not assume any obligation to update any statements set forth in this release.

 
 
 
 
 
COVERIS HOLDINGS S.A.
RECONCILIATION OF NET INCOME (LOSS) TO NON-GAAP ADJUSTED EBITDA
(Expressed in millions of U.S. dollars)
 
     
Three Months   Three Months
Ended Ended
31-Mar-17   31-Mar-16
 
U.S. GAAP Net income (loss) $ (18.2 ) $ (22.4 )
Interest expense, net 29.5 33.8
(Benefit) provision for income taxes (3.9 ) 4.4
Depreciation and amortization   37.0       36.5  
Non-GAAP EBITDA $ 44.4     $ 52.3  
 
Non-Operational Adjustments:
Accounting Manual Compliance - -
(Gain) loss on disposal of assets 0.1 1.7
Pension revaluation - -
Foreign currency exchange (gain) loss (1.7 ) 11.1
Other   -       0.9  
Total Non-Operational Adjustments $ (1.6 )   $ 13.7  
 
Special Items:
Restructuring and related relocation costs(a) 3.1 2.9
Management fees and expenses 2.4 2.1
Transaction related expenses(b) 0.5 0.1
Business improvement consulting cost 8.2 1.9
Other expenses(c)   2.0       2.2  
Total Special Items:   16.2       9.2  
Non-GAAP Adjusted EBITDA $ 59.0     $ 75.2  
 
(a) Costs associated primarily with various restructuring activities, employee relocation expenses or employee severance costs.
(b) Costs associated with transactions and acquisition costs.
(c) Costs associated with information technology, consulting, rebranding and other infrequent expenses.